eGenesis (Series D)
Funding Details
- Awarder
- Inbox
- Date Award
- June 09, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $191,000,000
Company Info
- Company Description
- eGenesis is a biotechnology company developing human-compatible engineered organs to address the global organ shortage.
- Market
- Organ transplantation
- Location
- Cambridge, MA, USA
- Coinvestors
- ARCH Ventures, Khosla Ventures, Farallon Capital Management, Alta Partners, Fresenius Medical Care Ventures, Leaps by Bayer, DaVita, Eisai Innovation, NATCO Pharmaceuticals, Parkwood Corporation